|
OMIM |
Link |
Information gain |
01 |
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
0.00346552
|
|
|
NPHS1
|
[NCBI]
|
0.00191313
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000905451
|
|
|
NPHS1
|
[NCBI]
|
0.000789116
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000630242
|
|
|
pierson syndrome
|
[NCBI]
|
0.000626816
|
|
|
FMF
|
[NCBI]
|
0.000567853
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000541204
|
|
|
SRN1
|
[NCBI]
|
0.000517854
|
|
|
IGAN1
|
[NCBI]
|
0.000406563
|
|
|
SLE
|
[NCBI]
|
0.000389772
|
|
|
NPHS2
|
[NCBI]
|
0.000315337
|
|
|
denys-drash syndrome
|
[NCBI]
|
0.000268537
|
|
|
LPL
|
[NCBI]
|
0.00024162
|
|
|
CD2AP
|
[NCBI]
|
0.000184307
|
|
|
LPG
|
[NCBI]
|
0.000176483
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
0.000176483
|
|
|
ALB
|
[NCBI]
|
0.000167494
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
0.000161927
|
|
|
LAMB2
|
[NCBI]
|
0.00015764
|
|
|
FSGS1
|
[NCBI]
|
0.000134055
|
|
|
WT1
|
[NCBI]
|
0.000132387
|
|
|
pulmonic stenosis and congenital nephrosis
|
[NCBI]
|
0.000103355
|
|
|
mesangial sclerosis, diffuse renal, with ocular abnormalities
|
[NCBI]
|
0.000103355
|
|
|
NPHS3
|
[NCBI]
|
0.000103355
|
|
|
atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease
|
[NCBI]
|
0.000103355
|
|
|
cryofibrinogenemia, familial primary
|
[NCBI]
|
0.000103355
|
|
|
MPV17
|
[NCBI]
|
9.87562e-05
|
|
|
LCAT
|
[NCBI]
|
7.48897e-05
|
|
|
AVP
|
[NCBI]
|
7.35325e-05
|
|
|
SLC9A3R2
|
[NCBI]
|
6.83068e-05
|
|
|
PLCE1
|
[NCBI]
|
6.83068e-05
|
|
|
RA
|
[NCBI]
|
6.81404e-05
|
|
|
NPPA
|
[NCBI]
|
6.29479e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
6.2906e-05
|
|
|
NPS
|
[NCBI]
|
6.19012e-05
|
|
|
ADIPOQ
|
[NCBI]
|
6.08099e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
5.96695e-05
|
|
|
frasier syndrome
|
[NCBI]
|
5.96695e-05
|
|
|
nephrosialidosis
|
[NCBI]
|
5.69826e-05
|
|
|
c-maf-inducing protein
|
[NCBI]
|
5.45363e-05
|
|
|
atransferrinemia
|
[NCBI]
|
5.26823e-05
|
|
|
WT1
|
[NCBI]
|
5.11783e-05
|
|
|
FCGRT
|
[NCBI]
|
4.93451e-05
|
|
|
APLP1
|
[NCBI]
|
4.93451e-05
|
|
|
PODXL
|
[NCBI]
|
4.93451e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
4.93087e-05
|
|
|
CP
|
[NCBI]
|
4.89937e-05
|
|
|
wagr syndrome
|
[NCBI]
|
4.78605e-05
|
|
|
IL12RB2
|
[NCBI]
|
4.59776e-05
|
|
|
myoclonic epilepsy, neonatal, with suppression-burst pattern
|
[NCBI]
|
4.53149e-05
|
|
|
cutis laxa, autosomal dominant
|
[NCBI]
|
4.41835e-05
|
|
|
ACE
|
[NCBI]
|
4.33822e-05
|
|
|
MAF
|
[NCBI]
|
4.14848e-05
|
|
|
CD80
|
[NCBI]
|
4.14848e-05
|
|
|
omenn syndrome
|
[NCBI]
|
4.03432e-05
|
|
|
PTPRO
|
[NCBI]
|
3.84158e-05
|
|
|
APOE
|
[NCBI]
|
3.7606e-05
|
|
|
HIDS
|
[NCBI]
|
3.6602e-05
|
|
|
VIL2
|
[NCBI]
|
3.60838e-05
|
|
|
AEZ
|
[NCBI]
|
3.53329e-05
|
|
|
TF
|
[NCBI]
|
3.49962e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
3.47368e-05
|
|
|
TFPI
|
[NCBI]
|
3.34617e-05
|
|
|
PLG
|
[NCBI]
|
3.32333e-05
|
|
|
SLC17A5
|
[NCBI]
|
3.26294e-05
|
|
|
cystinuria
|
[NCBI]
|
2.90118e-05
|
|
|
ATS
|
[NCBI]
|
2.75195e-05
|
|
|
CDG1A
|
[NCBI]
|
2.55439e-05
|
|
|
PAEP
|
[NCBI]
|
2.43899e-05
|
|
|
GDXY
|
[NCBI]
|
2.37985e-05
|
|
|
GC
|
[NCBI]
|
2.37985e-05
|
|
|
LOX
|
[NCBI]
|
2.29767e-05
|
|
|
UGB
|
[NCBI]
|
2.13045e-05
|
|
|
DMPK
|
[NCBI]
|
2.06723e-05
|
|
|
EPO
|
[NCBI]
|
2.00805e-05
|
|
|
B2M
|
[NCBI]
|
1.88388e-05
|
|
|
IL4
|
[NCBI]
|
1.85135e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.80744e-05
|
|
|
PF4
|
[NCBI]
|
1.76366e-05
|
|
|
STAR
|
[NCBI]
|
1.54539e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.44949e-05
|
|
|
PON1
|
[NCBI]
|
1.34781e-05
|
|
|
GHR
|
[NCBI]
|
1.18959e-05
|
|
|
MG
|
[NCBI]
|
1.11182e-05
|
|
|
PDCD8
|
[NCBI]
|
1.04679e-05
|
|
|
APOB
|
[NCBI]
|
1.03893e-05
|
|
|
SDC2
|
[NCBI]
|
1.01225e-05
|
|
|
TNF
|
[NCBI]
|
8.40371e-06
|
|
|
PRL
|
[NCBI]
|
7.88688e-06
|
|
|
PCNA
|
[NCBI]
|
7.40749e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.66452e-06
|
|
|
HP
|
[NCBI]
|
4.4499e-06
|
|
|
AFP
|
[NCBI]
|
4.31637e-06
|
|
|
GAPDH
|
[NCBI]
|
4.13983e-06
|
|
|
F3
|
[NCBI]
|
3.32833e-06
|
|
|
PTK2
|
[NCBI]
|
2.09798e-06
|
|
|
CVID
|
[NCBI]
|
1.96769e-06
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.65575e-06
|
|
|
HGF
|
[NCBI]
|
1.26327e-06
|
|
|
PTH
|
[NCBI]
|
1.16306e-06
|
|
|
ACHE
|
[NCBI]
|
4.72379e-07
|
|
|
temporal arteritis
|
[NCBI]
|
4.02187e-07
|
|
|
CAT
|
[NCBI]
|
1.69741e-07
|
|
|
ADA
|
[NCBI]
|
1.34624e-07
|
|
|
G6PD
|
[NCBI]
|
7.9807e-09
|
|
|
VEGF
|
[NCBI]
|
1.82389e-10
|
|